Dorzolamide Hydrochloride Solution
NDC Package 68083-489-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Dorzolamide Hydrochloride solution is dorzolamide Hydrochloride Ophthalmic Solution, USP is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. This formulation utilizes a solution delivery system. Marketed by Gland Pharma Limited, this product is identified by NDC 68083-489 and is authorized under FDA application ANDA215660.

Identification & Billing

NDC Package Code
68083-489-01
Package Description
1 BOTTLE in 1 CARTON / 10 mL in 1 BOTTLE
Product Code
68083-489
11-Digit Billing Format
68083048901
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Dorzolamide Hydrochloride
Non-Proprietary Name
Dorzolamide Hydrochloride
Substance Name
Dorzolamide Hydrochloride
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Ophthalmic - Administration to the external eye.
Active Ingredient(s)
DORZOLAMIDE HYDROCHLORIDE 20 mg/mL
Pharmacologic Class
Usage Information
Dorzolamide Hydrochloride Ophthalmic Solution, USP is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

Regulatory & Marketing

Labeler Name
Gland Pharma Limited
Product Type
Human Prescription Drug
FDA Application #
ANDA215660
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-27-2022
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68083-489-01 identifies a specific commercial package of 1 bottle in 1 carton / 10 ml in 1 bottle of Dorzolamide Hydrochloride, a human prescription drug labeled by Gland Pharma Limited. This solution is formulated for ophthalmic use and contains dorzolamide hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Gland Pharma Limited on January 27, 2022. The current certification is valid through December 31, 2027.

How is this Gland Pharma Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68083048901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68083-489-01
11-Digit CMS (5-4-2)
68083-0489-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.